Printer Friendly
The Free Library
19,595,260 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

AstraZeneca Adopts Spotfire as R&D-Wide eAnalytics Platform; Signs Multi-Year, Multi-Million Dollar Agreement with Spotfire.


Business/Technology Editors

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 28, 2001

Spotfire, Inc., the leading provider of Web-based decision analytics software, today announced that, as part of a multi-year, multi-million dollar contract with Spotfire, AstraZeneca, a world-leading pharmaceutical company, will deploy Spotfire software globally as a core application for decision makers. In addition Spotfire Professional Services (job) professional services - A department of a supplier providing consultancy and programming manpower for the supplier's products.  will assist AstraZeneca teams during the global implementation.

"Spotfire's decision analytics technology has been used by AstraZeneca for several years with excellent results," said Goran Wennberg, Global IS Manager, Discovery at AstraZeneca. "This agreement provides us with the ability to now deploy these solutions globally to help us maximize the benefits of the research informatics Same as information technology and information systems. The term is more widely used in Europe.  infrastructure that we've implemented. We have aggressive goals for R&D productivity, and our relationship with Spotfire will help us to provide our staff with the tools to achieve them."

"AstraZeneca is a longstanding customer that has been an outstanding partner for Spotfire," said Christopher Ahlberg, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  of Spotfire, Inc., "This agreement will allow AstraZeneca to build and deploy a world-leading decision making platform, and we look forward to continuing to work closely with them."

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of ethical (prescription) pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $15 billion and leading positions in sales of gastrointestinal gastrointestinal /gas·tro·in·tes·ti·nal/ (-in-tes´ti-n'l) pertaining to or communicating with the stomach and intestine.

gas·tro·in·tes·ti·nal
adj.
Abbr.
, oncology oncology /on·col·o·gy/ (ong-kol´ah-je) the sum of knowledge regarding tumors; the study of tumors.

on·col·o·gy
n.
, anesthesia anesthesia (ănĭsthē`zhə) [Gr.,=insensibility], loss of sensation, especially that of pain, induced by drugs, especially as a means of facilitating safe surgical procedures.  including pain management, cardiovascular, central nervous system (CNS See Continuous net settlement.

CNS

See continuous net settlement (CNS).
) and respiratory products.

About Spotfire, Inc.

Spotfire, Inc. is a leading provider of eAnalytic software and services that puts the power of decision-making at the center of its customers' businesses. Spotfire's solutions enable organizations around the world to improve the efficiency, the speed and the accuracy of their decision-making processes Presented below is a list of topics on decision-making and decision-making processes:

| width="" align="left" valign="top" |
  • Choice
  • Cybernetics
  • Decision
  • Decision making
  • Decision theory


| width="" align="left" valign="top" |
 by advancing both individual and networked analysis. The company maintains U.S. headquarters in Cambridge, Mass. and European headquarters in Goteborg, Sweden. Additional information can be found at http://www.spotfire.com.

Spotfire is a registered trademark of Spotfire, Inc. All other names or marks may be registered trademarks or trademarks of their respective owners and are hereby acknowledged.
COPYRIGHT 2001 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Feb 28, 2001
Words:357
Previous Article:IONA and CIBER to Host iPortal Server OS/390 Executive Briefing Series.
Next Article:IBP Statement on Tyson Announcement.
Topics:



Related Articles
Spotfire Closes $15 Million Financing; Funding Used to Further Development of Next Generation eAnalytic Applications and Fuel New Market Penetration.
ADVISORY/ Spotfire to Present At Bio CEO & Investor Conference.
REMINDER/ Spotfire to Present At Bio CEO & Investor Conference.
Carlsson Research Selects Spotfire Analytical Platform.
Biogen Deploys Spotfire DecisionSite to Deliver Advanced Analytical Capabilites.
Spotfire to Host Worldwide Users Conference.
ADVISORY/ Spotfire to Exhibit and Host Reception At the International Exposition and 71st Annual Meeting of the SEG: Society of Exploration...
Procter & Gamble, Biogen, Anadarko and Others Gain Discovery Advantage With Spotfire DecisionSite.
Spotfire and Rosetta Biosoftware Announce Three-Year Partnership; Spotfire and Rosetta to Integrate Two Widely Adopted Solutions for Gene Expression...
Spotfire Renews and Extends DecisionSite License Agreement to Pfizer to Support Global Drug Discovery.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles